ProFund VP Pharmaceuticals

Fund Profile

Fund profile

Fund manager

Profunds

Total assets

$10.74 mm

Liabilities

$316.38 k

Net assets

$10.42 mm

Number of holdings

53.00

53 Holdings

As of Sep 2024

Security	$Holding	Balance	% of Fund	Category	Position	Country
CORT Corcept Therapeutics Incorporated	450.63 k	9.74 k shares	4.32	Common equity	Long	USA
BMY Bristol-Myers Squibb Company	390.79 k	7.55 k shares	3.75	Common equity	Long	USA
JAZZ Jazz Pharmaceuticals plc	380.02 k	3.41 k shares	3.65	Common equity	Long	Ireland
ZTS Zoetis Inc.	379.43 k	1.94 k shares	3.64	Common equity	Long	USA
RPRX Royalty Pharma plc	378.72 k	13.39 k shares	3.63	Common equity	Long	UK
CTLT Catalent, Inc.	376.99 k	6.22 k shares	3.62	Common equity	Long	USA
ELAN Elanco Animal Health Incorporated	376.73 k	25.65 k shares	3.61	Common equity	Long	USA
VTRS Viatris Inc.	369.50 k	31.83 k shares	3.54	Common equity	Long	USA
PFE Pfizer Inc.	366.90 k	12.68 k shares	3.52	Common equity	Long	USA
MRK Merck & Co., Inc.	363.73 k	3.20 k shares	3.49	Common equity	Long	USA
JNJ Johnson & Johnson	363.34 k	2.24 k shares	3.49	Common equity	Long	USA
ITCI Intra-Cellular Therapies, Inc.	360.22 k	4.92 k shares	3.46	Common equity	Long	USA
LLY Eli Lilly and Company	356.15 k	402.00 shares	3.42	Common equity	Long	USA
AXSM Axsome Therapeutics, Inc.	355.98 k	3.96 k shares	3.42	Common equity	Long	USA
PRGO Perrigo Company plc	350.77 k	13.37 k shares	3.37	Common equity	Long	Ireland
OGN Organon & Co.	346.79 k	18.13 k shares	3.33	Common equity	Long	USA
SAVA Cassava Sciences, Inc.	310.84 k	10.56 k shares	2.98	Common equity	Long	USA
EWTX Edgewise Therapeutics, Inc.	298.98 k	11.20 k shares	2.87	Common equity	Long	USA
Invesco Government & Agency Portfolio	293.44 k	293.44 k shares	2.82	Short-term investment vehicle	N/A	USA
ARVN Arvinas, Inc.	268.66 k	10.91 k shares	2.58	Common equity	Long	USA
LBPH Longboard Pharmaceuticals, Inc.	247.44 k	7.42 k shares	2.37	Common equity	Long	USA
AMPH Amphastar Pharmaceuticals, Inc.	234.55 k	4.83 k shares	2.25	Common equity	Long	USA
PBH Prestige Consumer Healthcare Inc.	233.82 k	3.24 k shares	2.24	Common equity	Long	USA
TARS Tarsus Pharmaceuticals, Inc.	212.90 k	6.47 k shares	2.04	Common equity	Long	USA
COLL Collegium Pharmaceutical, Inc.	203.48 k	5.27 k shares	1.95	Common equity	Long	USA
SUPN Supernus Pharmaceuticals, Inc.	199.65 k	6.40 k shares	1.92	Common equity	Long	USA
PCRX Pacira BioSciences, Inc.	189.00 k	12.56 k shares	1.81	Common equity	Long	USA
ANIP ANI Pharmaceuticals, Inc.	168.18 k	2.82 k shares	1.61	Common equity	Long	USA
LGND Ligand Pharmaceuticals Incorporated	165.15 k	1.65 k shares	1.58	Common equity	Long	USA
HRMY Harmony Biosciences Holdings, Inc.	158.92 k	3.97 k shares	1.52	Common equity	Long	USA
OCUL Ocular Therapeutix, Inc.	135.63 k	15.59 k shares	1.30	Common equity	Long	USA
AMRX Amneal Pharmaceuticals, Inc.	132.60 k	15.94 k shares	1.27	Common equity	Long	USA
HROW Harrow Health, Inc.	132.00 k	2.94 k shares	1.27	Common equity	Long	USA
INVA Innoviva, Inc.	105.66 k	5.47 k shares	1.01	Common equity	Long	USA
PHAT Phathom Pharmaceuticals, Inc.	103.74 k	5.74 k shares	1.00	Common equity	Long	USA
NMRA Neumora Therapeutics, Inc. Common Stock	97.77 k	7.40 k shares	0.94	Common equity	Long	USA
FULC Fulcrum Therapeutics, Inc.	97.74 k	27.38 k shares	0.94	Common equity	Long	USA
Liquidia Corporation	95.78 k	9.58 k shares	0.92	Common equity	Long	USA
MNMD Mind Medicine (MindMed) Inc.	89.79 k	15.78 k shares	0.86	Common equity	Long	Canada
PLRX Pliant Therapeutics, Inc.	81.28 k	7.25 k shares	0.78	Common equity	Long	USA
EYPT EyePoint Pharmaceuticals, Inc.	77.36 k	9.68 k shares	0.74	Common equity	Long	USA
EOLS Evolus, Inc.	76.93 k	4.75 k shares	0.74	Common equity	Long	USA
ELVN Enliven Therapeutics, Inc.	70.67 k	2.77 k shares	0.68	Common equity	Long	USA
WVE Wave Life Sciences Ltd.	68.81 k	8.39 k shares	0.66	Common equity	Long	Singapore
NUVB Nuvation Bio Inc.	51.62 k	22.54 k shares	0.50	Common equity	Long	USA
Xeris Pharmaceuticals Inc	46.07 k	16.17 k shares	0.44	Common equity	Long	USA
HSBC SECURITIES USA INC	16.00 k	16.00 k principal	0.15	Repurchase agreement	Long	USA
SOCIETE GENERALE	12.00 k	12.00 k principal	0.12	Repurchase agreement	Long	USA
UMB FINANCIAL CORP	8.00 k	8.00 k principal	0.08	Repurchase agreement	Long	USA
Natwest Markets PLC	7.00 k	7.00 k principal	0.07	Repurchase agreement	Long	USA
CREDIT AGRICOLE CIB NY	7.00 k	7.00 k principal	0.07	Repurchase agreement	Long	USA
ROYAL BANK OF CANADA	5.00 k	5.00 k principal	0.05	Repurchase agreement	Long	USA
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. SELECT PHARMACEUTICALS INDEX GOLDMAN SACHS GROUP, INC	1.60 k	21.00 other units	0.02	Equity derivative	N/A	USA